New GSK partnership with Adaptimmune, page-25

Hi guys
Yes - I get impatient too, but it is a longer term hold. I also get "itchy trigger finger" when I see it still around 1 cent!!! It's bloody tempting to load up all I can get - but I have self imposed limits on my exposure, and I will only risk funds I feel I can lose, and I have already loaded up big time (by my modest standards).

All biotech is a risk. Of course - so are all stocks.

In terms of Biotech, IMU does have some very big "risk reducers" though. Confirmed target; same target already supports a multi-billion dollar market commercial drug; the immune response has been confirmed in the Ph 1a trial - and massively improved in lab tests since then through improved drug formulation; outstanding science and mgt team; excellent IP and patents.

It's still a risk, but I would be very very interested to hear of any other small and cheap Biotech which has a risk/reward profile better than Imugene. (As in REALLY interested).

Also happy to hear of any contrary view.

Cheers

Dave